US Stock MarketDetailed Quotes
CTMX CytomX
- 1.290
- -0.080-5.84%
Close Jun 18 16:00 ET
- 1.290
- 0.0000.00%
Post 19:50 ET
100.52MMarket Cap6.14P/E (TTM)
1.420High1.280Low2.20MVolume1.420Open1.370Pre Close2.91MTurnover3.77%Turnover RatioLossP/E (Static)77.92MShares5.85052wk High-3.17P/B75.32MFloat Cap1.04052wk Low--Dividend TTM58.39MShs Float35.000Historical High--Div YieldTTM10.22%Amplitude1.040Historical Low1.321Avg Price1Lot Size
CytomX Stock Forum
Sign in to post a comment
$CytomX(CTMX.US$ what is going on with this stock amy one know ?
1
1
CX-904 showcased a favorable safety profile, a critical factor in the administration and monitoring of patients in outpatient settings.
CytomX Therapeutics, Inc. (Nasdaq: CTMX) unveiled positive initial data from its ongoing CX-904 Phase 1a dose escalation clinical study. This pivotal study is centered around CX-904, an investigational PROBODY® T-cell engager that is both masked and conditionally activated, designed to target t...
CytomX Therapeutics, Inc. (Nasdaq: CTMX) unveiled positive initial data from its ongoing CX-904 Phase 1a dose escalation clinical study. This pivotal study is centered around CX-904, an investigational PROBODY® T-cell engager that is both masked and conditionally activated, designed to target t...
3
$CytomX(CTMX.US$ Ouchie!
1
$CytomX(CTMX.US$ pik me up 8
$CytomX(CTMX.US$ dropping hard?
2
Pioneering a New Era in Cancer Treatment: CytomX and Merck's Strategic Collaboration on CX-801.
Striding towards revolutionizing cancer therapy, CytomX Therapeutics, Inc. (Nasdaq: CTMX) has announced a clinical trial collaboration and supply agreement with pharmaceutical giant Merck (known as MSD outside of the US and Canada). This collaboration is set to explore the therapeutic potential of CX-801, a novel, dually-m...
Striding towards revolutionizing cancer therapy, CytomX Therapeutics, Inc. (Nasdaq: CTMX) has announced a clinical trial collaboration and supply agreement with pharmaceutical giant Merck (known as MSD outside of the US and Canada). This collaboration is set to explore the therapeutic potential of CX-801, a novel, dually-m...
3
$CytomX(CTMX.US$
Imagine delivering a 100% revenue beat and 350% eps beat and you shed 35%, truly a work of beauty
Imagine delivering a 100% revenue beat and 350% eps beat and you shed 35%, truly a work of beauty
1
$CytomX(CTMX.US$ Up almost 40% from that terrible crash!
1
2
$CytomX(CTMX.US$ From as high as 9.5 to current price of 2+, i hope not many people caught bagholding here.
5
9
No comment yet
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
73409474 : Shareholder meeting. Merck collab. Naked shorted which is why it won't go over 2ish. I'm waiting. I don't pay interest bc I don't short. Especially naked. And can't lose unknown amounts of money. They can. So I wait.